The Integrated Substance Abuse Programs at the University of California, Los Angeles (UCLA ISAP) is providing training services and technical assistance across the state of California to improve, expand and increase access to MAT services. The purpose of this program is to identify the barriers to prescribing buprenorphine and provide targeted mentorship, training, and technical assistance to address those barriers.
At project initiation in 2018, ISAP conducted a statewide survey to assess treatment needs of waivered prescribers, which served as the basis of the training/technical assistance plans. With continuing funds in 2020 and 2022, the program expanded to address fentanyl and stimulant use disorders, as well as the specific needs of youth and persons experiencing homelessness or unstable housing.
Through the Provider Support Initiative, providers, prescribers, and MAT team members can access consultation and mentorship; access live and on-demand web-based trainings; and participate in CA MAT ECHO clinics, which offer case-based learning utilizing the Project Extension for Community Healthcare Outcomes (Project ECHO™) web-based consultation mechanism.
This project receives funding from the State Opioid Response (SOR) grant through the Substance Abuse and Mental Health Services Administration (SAMHSA).
Visit the Provider Support Initiative page on the UCLA OASIS-TTA website to learn more.